Growth Metrics

PAVmed (PAVM) Return on Capital Employed (2021 - 2025)

PAVmed (PAVM) has 5 years of Return on Capital Employed data on record, last reported at 0.66% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.66%; the TTM value through Sep 2025 reached 0.66%, changed N/A, while the annual FY2024 figure was 12.51%, 604.0% up from the prior year.
  • Return on Capital Employed reached 0.66% in Q3 2025 per PAVM's latest filing, up from 0.77% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 11.57% in Q3 2023 and bottomed at 10.11% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 0.22%, with a median of 0.95% recorded in 2021.
  • The widest YoY moves for Return on Capital Employed: up 1400bps in 2023, down -914bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.95% in 2021, then tumbled by -337bps to 4.14% in 2022, then skyrocketed by 200bps to 4.14% in 2023, then soared by 57bps to 6.49% in 2024, then crashed by -110bps to 0.66% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.66% in Q3 2025, 0.77% in Q2 2025, and 1.2% in Q1 2025.